## Abstract Knowledge of reβprogramming in cancer cells with metabolic differences from their normal counterparts has resulted in new examination of therapeutic approaches. Several studies of the role of tumor mitochondria in cancer have led to the development of nonβgenotoxic therapies which targe
β¦ LIBER β¦
Endothelin-1 as a Target for Therapeutic Intervention in Prostate Cancer
β Scribed by E. Scott Kopetz; Joel B. Nelson; Michael A. Carducci
- Book ID
- 110339776
- Publisher
- Springer US
- Year
- 2002
- Tongue
- English
- Weight
- 316 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0167-6997
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Targeting mitochondria as a therapeutic
β
Charles E. Wenner
π
Article
π
2011
π
John Wiley and Sons
π
English
β 367 KB
π 1 views
The macrophage foam cell as a target for
β
Li, Andrew C.; Glass, Christopher K.
π
Article
π
2002
π
Nature Publishing Group
π
English
β 406 KB
Src as a therapeutic target in men with
β
Fred Saad
π
Article
π
2009
π
John Wiley and Sons
π
English
β 305 KB
Cyclin D as a therapeutic target in canc
β
Musgrove, Elizabeth A.; Caldon, C. Elizabeth; Barraclough, Jane; Stone, Andrew;
π
Article
π
2011
π
Nature Publishing Group
π
English
β 583 KB
Targeting Tankyrase 1 as a therapeutic s
β
McCabe, N; Cerone, M A; Ohishi, T; Seimiya, H; Lord, C J; Ashworth, A
π
Article
π
2009
π
Nature Publishing Group
π
English
β 203 KB
Angiogenesis as a strategic target for p
β
Yong Li; Paul J. Cozzi
π
Article
π
2009
π
John Wiley and Sons
π
English
β 419 KB
## Abstract It is becoming increasingly clear that angiogenesis plays a crucial role in prostate cancer (CaP) survival, progression, and metastasis. Tumor angiogenesis is a hallmark of advanced cancers and an attractive treatment target in multiple solid tumors. By understanding the molecular basis